Hester Biosciences Ltd completes sale of equity investment in Texas Lifesciences Private Limited
Hester Biosciences Ltd has completed the divestment of its entire equity stake in Texas Lifesciences Private Limited (TLPL), concluding the sale transaction on 8 July 2026. The company transferred its remaining shares to existing stakeholders of TLPL for an aggregate consideration of INR 23 million.The transaction involved the transfer of 543,248 equity shares representing an initial holding of 11% in TLPL’s paid-up equity share capital. This move reduces Hester Biosciences Ltd's investment in Texas Lifesciences Private Limited to Nil.The sale was executed in accordance with terms previously approved by the Board of Directors of Hester...